Every energy technology that eventually becomes “bankable” has to survive an awkward middle stage first, the point where the tech has been proven in a lab or pilot but hasn’t yet run at commercial scale long enough for lenders to trust it. These first-of-a-kind (“FOAK”) projects are demonstration- and deployment-stage projects being brought to final […]

SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, delivered another quarter of rapid top-line growth as demand for its SSi Mantra surgical robotic system continued to expand. The company reported second-quarter 2026 revenue of $13.9 million, an increase of 39.4% from $10.0 million a year earlier. Gross profit increased 20.0% to […]

The recent annual financial results posted by Earth Science Tech (OTC: ETST) reflect significant success and growth, which the diversified holding company attributes to an overarching focus on optimizing internal operations. The company, for instance, logged consecutive year-over-year increases in revenue and gross profit in the two years to March 31, 2026 (https://ibn.fm/GQzTa), and has […]

For development-stage medical technology companies, regulatory approval and commercial revenue often sit years apart. A trial needs to be finished, a submission must clear review, manufacturing has to scale, surgeons must be trained and distribution has to be built. Companies able to run those workstreams in parallel rather than in sequence compress the distance between […]

Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid advertising.  Powermax Minerals (CSE: PMAX) (OTCQB: PWMXF), a Canadian mineral exploration company focused on rare earth projects, is continuing exploration across its North American rare earth element portfolio as demand for critical minerals becomes increasingly linked to energy security and efforts to […]

Aging populations are pushing joint disease higher on the orthopedic agenda, with cartilage damage representing one of the field’s largest unmet needs. Current treatments have demonstrated clinical utility, but they remain difficult to deliver efficiently and economically on scale. That gap is where off-the-shelf therapies can deliver high value, and where manufacturing know-how and intellectual […]

For years, the promise of blockchain in financial markets centered on putting traditional assets on chain. Now, the harder question is emerging: what infrastructure is needed to make those assets useful on an institutional scale? Tokenized real-world assets, or RWAs, are beginning to move beyond experimentation. Tokenized Treasury funds, private credit products, commodities and other […]

Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising. Multiple sclerosis is quietly shifting how drugmakers define success. Instead of judging a therapy mainly by whether it reduces relapses, developers are chasing the slower, harder-to-treat processes that drive long-term disability, and Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) is one of the […]

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising. For decades, military advantage came from building better aircraft. Today’s battlefield increasingly rewards something different: making inexpensive aircraft smarter. As drones become cheaper and more disposable, software is becoming the primary source of military advantage. A single guided munition […]

Disseminated on behalf of Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) and may include paid advertising. Gold’s recent strength has increasingly been driven by structural demand rather than short-term speculation, and 2026 has provided investors with no shortage of reasons to seek safe-haven assets. Amid that backdrop sits Lahontan Gold (TSX.V: LG) (OTCQB: LGCXF), a […]